Friday, September 18, 2020 2:09:19 PM
Needs to be sold, can't be fixed with JT.
JT is a cancer, he must be removed. The rest of the board is metastasized cancer, spawning from JT.
Anyone supporting "fixing" the company is tacitly supporting JT and the board. The company must be sold because removing the entirety is untenable. They should sell the company into capable hands, it cannot be fixed with those in control. They will lose the en banc. They will fail in Europe, if they ever get approval at all. At this rate, we'll need another dilution before the approval even happens, despite prior promises of approval by end of 2020, now we are looking at not even a "recommendation for approval" until probably mid 2021, because JT will keep slow walking it.
">" />
"Tough times don't last....tough people do"
Recent AMRN News
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
